Indications
Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients.Treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Composition
- Active substance
- darbepoetin alfa
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Nespo
- Active substance
- darbepoetin alfa
- ATC code
- B03XA02
- Therapeutic area
- Kidney Failure, Chronic, Anemia, Cancer
- Marketing authorisation holder
- Dompé Biotec S.p.A.
- Status
- Withdrawn